Autolus Therapeutics Ltd | AUTL - Current Assets

Stock Price
1.38
Daily Change
0 0%
Monthly
-25.81%
Yearly
-36.41%
Q1 Forecast
1.34

Autolus Therapeutics Ltd reported $514.58M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AstraZeneca USD 29.94B 1B Sep/2025
Autolus Therapeutics Ltd USD 514.58M 59.67M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Novartis USD 28.2B 2.26B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Silence Therapeutics USD 133.63M 14.92M Sep/2025